| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.36B | 44.77B | 44.31B | 42.77B | 36.40B | 34.06B |
| Gross Profit | 16.58B | 17.61B | 16.89B | 16.80B | 15.13B | 15.97B |
| EBITDA | 4.60B | 5.63B | 4.53B | 5.79B | 4.22B | 5.80B |
| Net Income | 1.65B | 2.06B | 1.63B | 2.49B | 1.44B | 2.54B |
Balance Sheet | ||||||
| Total Assets | 27.20B | 30.34B | 28.15B | 28.41B | 25.96B | 28.20B |
| Cash, Cash Equivalents and Short-Term Investments | 10.37B | 13.75B | 11.73B | 11.49B | 10.80B | 14.66B |
| Total Debt | 10.18M | 321.22M | 279.67M | 173.35M | 127.72M | 372.48M |
| Total Liabilities | 5.40B | 6.71B | 5.72B | 6.55B | 5.81B | 6.95B |
| Stockholders Equity | 21.80B | 23.63B | 22.42B | 21.86B | 20.15B | 21.25B |
Cash Flow | ||||||
| Free Cash Flow | 576.95M | 3.60B | 1.78B | 2.30B | -896.40M | 3.88B |
| Operating Cash Flow | 1.01B | 5.19B | 3.86B | 3.94B | 904.31M | 5.69B |
| Investing Cash Flow | -579.90M | -2.13B | -2.60B | -2.25B | -2.33B | -2.27B |
| Financing Cash Flow | -516.05M | -1.04B | -1.04B | -1.01B | -2.44B | -1.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥267.43B | 26.99 | ― | 2.18% | 8.08% | -27.93% | |
73 Outperform | ¥2.38T | 17.78 | 15.67% | 1.94% | 8.60% | 10.04% | |
69 Neutral | ¥34.17B | 15.79 | ― | 3.63% | 1.04% | 26.51% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥248.33B | 12.92 | ― | 1.51% | ― | ― | |
53 Neutral | ¥91.67B | 18.63 | ― | ― | 52.78% | -7.69% | |
51 Neutral | ¥49.79B | 17.63 | ― | ― | 6.93% | ― |